Welcome


The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft which is combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.


The EANM 2017 congress


The European Association of Nuclear Medicine (EANM) meets annualy in an European city to discuss the newest trends and findings in the field of nuclear medicine. The EANM congress provides great
Austrian Platform for Personalized Medicine


Between the 19th and 20th of October 2017 the opening and scientific symposium of the Austrian Platform for Personalized Medicine took place. The Medical University of Vienna
4th National Congress of the Korean Society of Radiopharmaceuticals and Molecular Probes 2017


Prof. Dr. Thomas L. Mindt, Head of Imaging Biomarkers, was invited to deliver the plenary lecture at the 4th national congress

Share This: